June 3, 2020 / 12:29 PM / a month ago

BRIEF-Diasorin Liaison SARS-CoV-2 S1/S2 IgG Test Receives Approval For Commercialization In Brazil

June 3 (Reuters) - DiaSorin SpA:

* LIAISON SARS-COV-2 S1 S2 IGG TEST RECEIVES APPROVAL FROM ANVISA IN BRAZIL Source text for Eikon: Further company coverage: (Gdansk Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below